EDITORIAL
Published on 10 Jan 2025
Editorial: Biologic drugs in immune-mediated inflammatory diseases, validation, drug-utilization, effectiveness, regulation, costs, and safety in the real-world
doi 10.3389/fphar.2024.1542453
- 364 views
- Frontiers in Pharmacology
- Pharmacoepidemiology
- Research Topics
- Biologic Drugs in Immune-Mediated Inflammatory Diseases: Validation, Drug-Utilization, Effectiveness, Regulation, Costs, and Safety in the Real World
Biologic Drugs in Immune-Mediated Inflammatory Diseases: Validation, Drug-Utilization, Effectiveness, Regulation, Costs, and Safety in the Real World
5,601
Total downloads
26k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 16 Oct 2024
Effectiveness of biologic therapies in achieving treatment targets in inflammatory bowel disease; real-world data from the Middle East (ENROLL study)
doi 10.3389/fphar.2024.1388043
- 781 views
SYSTEMATIC REVIEW
Published on 10 Oct 2024
A systematic review and meta-analysis of the efficacy and safety of iguratimod in the treatment of inflammatory arthritis and degenerative arthritis
doi 10.3389/fphar.2024.1440584
- 1,119 views
REVIEW
Published on 24 Jul 2024
Anti-TNFα in inflammatory bowel disease: from originators to biosimilars
doi 10.3389/fphar.2024.1424606
- 1,865 views
- 1 citation
ORIGINAL RESEARCH
Published on 14 Jun 2024
Hepatitis-related adverse events associated with immune checkpoint inhibitors in cancer patients: an observational, retrospective, pharmacovigilance study using the FAERS database
doi 10.3389/fphar.2024.1383212
- 1,306 views
- 2 citations
ORIGINAL RESEARCH
Published on 10 Jun 2024
Healthcare resource utilization patterns in psoriasis patients using biologic and conventional treatments in Finland
doi 10.3389/fimmu.2024.1374829
- 1,178 views
ORIGINAL RESEARCH
Published on 14 Nov 2023
Parasitic infections related to anti-type 2 immunity monoclonal antibodies: a disproportionality analysis in the food and drug administration’s adverse event reporting system (FAERS)
doi 10.3389/fphar.2023.1276340
- 3,952 views
- 6 citations
ORIGINAL RESEARCH
Published on 30 Oct 2023
Do disease-modifying antirheumatic drugs and non-steroidal anti-inflammatory drugs increase the burden on ankylosing spondylitis patients with mild-moderate COVID-19? evidence from a retrospective cohort study
doi 10.3389/fphar.2023.1266915
- 1,298 views
- 2 citations
ORIGINAL RESEARCH
Published on 25 Sep 2023
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy
doi 10.3389/fphar.2023.1244486
- 1,431 views
CASE REPORT
Published on 23 May 2023
Successful treatment of a refractory intestinal Behcet’s disease with an oncology history by Vedolizumab: a case report and literature review
doi 10.3389/fimmu.2023.1205046
- 2,672 views
- 1 citation
